首页> 外文期刊>The journal of clinical psychiatry >Assessing the Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression
【24h】

Assessing the Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression

机译:评估难治性抑郁症和难治性抑郁症的危险因素

获取原文
获取原文并翻译 | 示例
           

摘要

Depression is the leading cause of disability among people across the globe, according to the World Health Organization. Among those who have been diagnosed, many fail to achieve remission after following recommended antidepressant medication and psychosocial therapies. In particular, difficult-to-treat and treatment-resistant depression may cause severe impairments for patients, including diminished cognitive functioning, increased medical bills, and decreased workplace performance, as well as an increased risk of developing comorbid illnesses. However, many tools are available to clinicians for identifying treatment-resistant depression, including rating scales such as the 9-question Patient Health Questionnaire (PHQ-9) and the Quick Inventory of Depressive Symptomatology (QIDS-SR16), as well as clinical evidence related to risk factors for difficult-to-treat or treatment-resistant depression. Accurately identifying treatment-resistant depression is the first step toward changing treatment regimens to help patients achieve remission.
机译:根据世界卫生组织的数据,抑郁症是导致全球残疾人致残的主要原因。在被诊断出的人中,许多人在遵循推荐的抗抑郁药物和心理社会疗法后未能获得缓解。特别是,难以治疗且难以治疗的抑郁症可能会给患者造成严重损害,包括认知功能下降,医疗费用增加和工作场所绩效下降,以及增加合并症的风险。但是,临床医生可以使用许多工具来识别具有抗药性的抑郁症,包括9级患者健康问卷(PHQ-9)和抑郁症状快速调查表(QIDS-SR16)等评估量表以及临床证据。与难以治疗或难以治疗的抑郁症的危险因素有关。准确识别耐治疗性抑郁症是改变治疗方案以帮助患者获得缓解的第一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号